[November 30, 2006]

Indegene acquires MedCases, LLC

(Science Letter Via Thomson Dialog NewsEdge)
Indegene, a provider of medical education, marketing services, and sales training, has acquired MedCases, LLC, an Accreditation Council for Continuing Medical Education (ACCME)-accredited interactive continuing medical education (CME) provider in the United States.

MedCases will continue to operate as an independent legal entity and focus on its core mission to provide innovative CME programs.

Since 1998, MedCases has been a pioneer in peer-reviewed, clinical educational programs using highly interactive simulated patient encounters. According to Indegene, MedCases uses an Internet-based system to deliver comprehensive, cost-effective learning with applications for practicing physicians, pharmaceutical companies, academic medical centers, and healthcare delivery organizations. MedCases has delivered more than 150 CME programs and has a library of more than 500 proprietary teaching cases spread across 25 medical specialties. Since 2001, MedCases has had more than 300,000 visitors to CME programs and over 100,000 issued credits.

MedCases also provides medical education tools to help enhance the overall learning experiences of medical students and residents. The interactive format allows faculty to assign cases, review progress, and evaluate scores via the Internet while providing students and residents an opportunity to develop clinical expertise online in a full range of specialty-specific disease states and diagnoses.

With this acquisition, the Indegene worldwide group expands its presence in the U.S. market through two independent companies: Medsn, Inc., and MedCases, LLC. Medsn is a leader in promotional medical marketing, sales training, and competitive intelligence services with more than 50 employees across offices in New Jersey, Los Angeles, California, and Chicago, Illinois. MedCases is based out of Philadelphia, Pennsylvania.

The new acquisition reflects the growing pharmaceutical industry trend toward complete separation of support for accredited CME programs and nonaccredited programs deemed promotional by the U.S. Food & Drug Administration, a move prompted by stricter guidelines issued by the ACCME and increased federal scrutiny.

"We are continuing to pioneer a unique model for providing accredited medical education as well as promotional marketing and sales training services that leverage global delivery capabilities and physician relationships from multiple geographies," said Dr. Rajesh Nair, president and CEO of Indegene. "With a footprint that currently spans the United States, Southeast Asia, India, and Australia, Indegene is poised to fundamentally change the dynamics of the industry by leveraging our hybrid global delivery model. This model allows us to provide our clients with a fresh, alternate option to resolve the multiple challenges they face in today's competitive markets."

This article was prepared by Science Letter editors from staff and other reports. Copyright 2006, Science Letter via

Copyright 2006 Science Letter via

[ Back To NFVZone's Homepage ]